Rep. Don Bacon, U.S. Representative for Nebraska's 2nd District | Don Bacon Official Website
Rep. Don Bacon, U.S. Representative for Nebraska's 2nd District | Don Bacon Official Website
Representatives Don Bacon and Joe Morelle have introduced legislation aimed at advancing research, treatment, and prevention of Triple-Negative Breast Cancer (TNBC). The initiative includes the bipartisan Triple-Negative Breast Cancer Research and Education Act and a resolution by Rep. Morelle to designate March 3rd as Triple-Negative Breast Cancer Awareness Day.
Rep. Bacon expressed personal motivation for supporting the legislation, saying, “I'm proud to co-sponsor the bipartisan TNBC Research and Education Act to raise awareness for a cause deeply personal to my family and me. Nineteen years ago, I lost my beloved sister, Beth, to breast cancer when she was only 39 years old.” He emphasized the importance of dedicated research in defeating breast cancer.
Congressman Joe Morelle also highlighted personal reasons for his involvement: “Far too many families, including my own, have felt the pain of losing a loved one to triple-negative breast cancer. This aggressive disease must be met with an equally aggressive response.” He introduced the legislation in honor of his daughter Lauren.
Hayley Dinerman from the Triple Negative Breast Cancer Foundation praised the efforts: “We are thrilled to be here for the introduction of the TNBC Education Act and Representative Joe Morelle’s annual resolution recognizing March 3rd as TNBC Awareness Day.”
Ricki Fairley from TOUCH, the Black Breast Cancer Alliance, pointed out racial disparities in TNBC impact: “Triple negative breast cancer impacts Black women at three times the rate of white women. 40% of TNBC patients are under the age of 40.”
Breast cancers are often identified by receptors that drive their growth; however, TNBC lacks these receptors, making it resistant to many treatments. It accounts for 10 to 20 percent of female breast cancer diagnoses annually.
The proposed act aims to direct NIH and HHS to expand TNBC research, improve information sharing among health agencies and providers, and increase public understanding of TNBC risks and treatments.